Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation

BACKGROUND: Diabetic kidney disease (DKD) has been the leading cause of chronic kidney disease in developed countries. Evidence of the benefits of resveratrol (RES) for the treatment of DKD is accumulating. However, comprehensive therapeutic targets and underlying mechanisms through which RES exerts...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shengnan, Li, Bo, Chen, Lei, Jiang, Hongli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258995/
https://www.ncbi.nlm.nih.gov/pubmed/37308949
http://dx.doi.org/10.1186/s12967-023-04233-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258995/
https://www.ncbi.nlm.nih.gov/pubmed/37308949
http://dx.doi.org/10.1186/s12967-023-04233-0

Ejemplares similares